Evidence map›Paper›PMID 42653781›Full record

ArticlePharmaceuticals (Basel, Switzerland)2026

Spray-Dried Eugenol Microparticles: Physicochemical Characterization and Enhanced Antibacterial Activity.

Vicenta Albarral Ávila, Anna Nardi-Ricart, Aitor Caballero-Román, Lara Martínez Pettina, David Miñana-Galbis, Montserrat Miñarro Carmona

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vicenta Albarral ÁvilaMicrobiology Section, Department of Biology, Healthcare and Environment, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Av Joan XXIII, 27-31, 08028 Barcelona, Catalonia, Spain.ORCID 0000-0002-9688-1521
Anna Nardi-RicartPharmacy, Pharmaceutical Technology, and Physico-Chemical Department, Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Catalonia, Spain.ORCID 0000-0001-9548-3903
Aitor Caballero-RománPharmacy, Pharmaceutical Technology, and Physico-Chemical Department, Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Catalonia, Spain.ORCID 0000-0002-1541-8237
Lara Martínez PettinaMicrobiology Section, Department of Biology, Healthcare and Environment, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Av Joan XXIII, 27-31, 08028 Barcelona, Catalonia, Spain.
David Miñana-GalbisMicrobiology Section, Department of Biology, Healthcare and Environment, Faculty of Pharmacy and Food Sciences, Universitat de Barcelona, Av Joan XXIII, 27-31, 08028 Barcelona, Catalonia, Spain.ORCID 0000-0003-2281-0402
Montserrat Miñarro CarmonaPharmacy, Pharmaceutical Technology, and Physico-Chemical Department, Universitat de Barcelona, Av. Joan XXIII, 27-31, 08028 Barcelona, Catalonia, Spain.ORCID 0000-0002-6795-2685

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

antimicrobial resistancebiopolymerseugenolmicroencapsulationminimum inhibitory concentrationspray drying

Identifiers

PMID42653781
PMCPMC13516020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.